Search

Your search keyword '"Lorens K"' showing total 7 results
Start Over Author "Lorens K" Publication Year Range Last 10 years
7 results on '"Lorens K"'

2. OA01.07 A Phase II Study of the Oral Selective AXL Inhibitor Bemcentinib with Pembrolizumab in Patients with Advanced NSCLC

Author

Krebs, M.G., primary, Helland, Å., additional, Carcereny Costa, E., additional, Arriola Aperribay, E., additional, Dómine Gómez, M., additional, Trigo Pérez, J., additional, Thompson, J., additional, Strauss, J., additional, Ortega Granados, A.L., additional, Felip, E., additional, Schmidt, E., additional, Chisamore, M., additional, Madeleine, N., additional, Rayford, A., additional, Lorens, K., additional, Siddiqui, A., additional, Gabra, H., additional, Nautiyal, J., additional, Micklem, D., additional, Lorens, J., additional, and Spicer, J., additional

Published
2021
Full Text
View/download PDF

5. P1.01-72 A Phase II Study of Selective AXL Inhibitor Bemcentinib and Pembrolizumab in Patients with NSCLC Refractory to Anti-PD(L)1

Author

Krebs, M., primary, Brunsvig, P., additional, Helland, Å., additional, Viñolas, N., additional, Aix, S., additional, Carcereny, E., additional, Gomez, M. Dómine, additional, Perez, J.M. Trigo, additional, Arriola, E., additional, Campelo, R. Garcia, additional, Spicer, J., additional, Thompson, J., additional, Granados, A.L. Ortega, additional, Holt, R., additional, Smethurst, D., additional, Lorens, J., additional, Shoaib, M., additional, Siddiqui, A., additional, Schoelermann, J., additional, Lorens, K., additional, Schmidt, E., additional, Chisamore, M.J., additional, and Felip, E., additional

Published
2019
Full Text
View/download PDF

6. MA03.06 Efficacy Results of Selective AXL Inhibitor Bemcentinib with Pembrolizumab Following Chemotherapy in Patients with NSCLC

Author

Felip, E., primary, Brunsvig, P., additional, Helland, Å., additional, Viñolas, N., additional, Aix, S., additional, Carcereny, E., additional, Gomez, M. Dómine, additional, Perez, J.M. Trigo, additional, Arriola, E., additional, Campelo, R. Garcia, additional, Spicer, J., additional, Thompson, J., additional, Granados, A.L. Ortega, additional, Holt, R., additional, Smethurst, D., additional, Lorens, J., additional, Shoaib, M., additional, Siddiqui, A., additional, Schoelermann, J., additional, Lorens, K., additional, Schmidt, E., additional, Chisamore, M.J., additional, and Krebs, M., additional

Published
2019
Full Text
View/download PDF

7. PF259 THE COMBINATION OF BEMCENTINIB, A NOVEL, ORAL, SELECTIVE AXL-INHIBITOR AND LOW-DOSE CYTARABINE YIELDS DURABLE RESPONSES IN AML PATIENTS UNFIT FOR INTENSIVE CHEMOTHERAPY

Author

Loges, S., primary, Heuser, M., additional, Chromik, J., additional, Vigil, C.E., additional, Paschka, P., additional, Re, F., additional, Di Renzo, N., additional, Lemoli, R., additional, Mattei, D., additional, Ben Batalla, I., additional, Hellesøy, M., additional, Micklem, D., additional, Holt, R.J., additional, Schoelermann, J., additional, Lorens, K., additional, Lorens, J.B., additional, Shoaib, M., additional, Aly, H., additional, Brown, A., additional, Fiedler, W.M., additional, Cortes, J.E., additional, and Gjertsen, B.T., additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results